Targeting the Snail1-ATGL-Ferroptosis-EMT Axis via AKT-GSK3β Signaling: Low-Dose Colchicine Attenuates Idiopathic Pulmonary Fibrosis.
BACKGROUND The mechanisms underlying colchicine's (COL's) anti-fibrotic effects in idiopathic pulmonary fibrosis (IPF) remain unclear. Ferroptosis-associated redox imbalance and epithelial-mesenchymal transition (EMT) are well-recognized central drivers of IPF progression, yet the upstream regulatory mechanisms linking...